Fertility After Surgery in Testicular Cancer Patients
Author Information
Author(s): Jacobsen K D, Ous S, Wæhre H, Trasti H, Stenwig A E, Lien H H, Aass N, Fosså S D
Primary Institution: The Norwegian Radium Hospital, Oslo 0310, Norway
Hypothesis
The study aims to evaluate fertility outcomes after different types of post-chemotherapy retroperitoneal lymph node dissection (RPLND) in testicular cancer patients.
Conclusion
Nerve-sparing RPLND preserves antegrade ejaculation in 89% of patients, and at least 50% of those attempting fatherhood achieved it post-treatment.
Supporting Evidence
- Antegrade ejaculation was preserved in 11% of patients after modified bilateral template RPLND.
- Antegrade ejaculation was preserved in 89% of patients after nerve-sparing RPLND.
- The median ejaculatory volume decreased post-operatively.
- Serum FSH increased post-operatively.
- Sperm density remained unchanged post-operatively.
- Fifty-six patients attempted fatherhood after treatment.
- Twenty-seven patients fathered at least one child after treatment.
- Nine patients achieved fatherhood through assisted fertilization.
Takeaway
This study looked at how surgery affects the ability to have children for men who had testicular cancer. It found that a special type of surgery helps many men keep their ability to ejaculate and have kids.
Methodology
The study assessed pre- and post-treatment fertility through sperm analysis, serum FSH levels, and information on ejaculation and paternity.
Participant Demographics
Patients with metastatic testicular cancer who underwent post-chemotherapy RPLND between 1980 and 1994.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website